Cailu H. Song
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Dual targeting of ferroptosis and immune evasion: STAT3 inhibition as a one-two punch for breast cancer immunotherapy.
Journal: Journal of translational internal medicine
Published: August 27, 2026
Single-cell sequencing profiling of intratumoral heterogeneity and immunosuppressive microenvironment in primary thyroid cancer and lymph node metastases.
Journal: Oncoimmunology
Published: July 10, 2026
ZBED6-driven nucleotide metabolic reprogramming improves sensitivity to anti-PD1 therapy in NK/T cell lymphoma.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: December 23, 2025
CircPLK1 upregulates ETS1 to confer anthracycline resistance in triple-negative breast cancer.
Journal: Journal of translational internal medicine
Published: September 02, 2025
Hijacking the bone niche: mechanistic insights into bone metastasis in breast cancer.
Journal: Bone research
Published: August 25, 2025
Isoliquiritigenin Inhibits Triple-Negative Breast Cancer Progression via Targeting the IRF5/SLC7A5/IDO1-Mediated Tryptophan Metabolism Pathway.
Journal: Oncology research
Published: May 25, 2025
PRMT1-Mediated PARP1 Methylation Drives Lung Metastasis and Chemoresistance via P65 Activation in Triple-Negative Breast Cancer.
Journal: Research (Washington, D.C.)
Published: May 15, 2025
Erratum to: Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway.
Journal: Science China. Life sciences
Published: April 16, 2025
Precision targeted therapy and immunotherapy in breast cancer: Advances and clinical frontiers.
Journal: Chinese medical journal
Published: February 17, 2025
Comparison of pegaspargase with concurrent radiation vs. P-GEMOX with sequential radiation in early-stage NK/T-cell lymphoma.
Journal: Oncology research
Published: August 07, 2024
Fibroblast Growth Factor Receptor 4 Promotes Triple-Negative Breast Cancer Progression via Regulating Fatty Acid Metabolism Through the AKT/RYR2 Signaling.
Journal: Cancer medicine
Published: August 06, 2024
Last Updated: 09/26/2026